αυβ3 Suppresses the RhoA-LIMK1 Pathway in K1735 Melanoma

Authors:

Abstract
Mucocutaneous melanoma has a five-year survival rate of less than 10 percent. The αvβ3 integrin promotes invasion, which requires actin reorganization by cofilin. The authors previously showed that cofilin and αvβ3 promote invasion. K1735 melanoma has several clones, each with different levels of αvβ3. The authors found that expression of αvβ3 suppresses activation of RhoA thus inhibiting LIMK1 phosphorylation of cofilin. This indicates that αvβ3 integrin suppresses the RhoA/ROCK/LIMK1 pathway.

This publication has 15 references indexed in Scilit: